Indefinite Delivery Contract SPE2DX15D9230

DMS Pharmaceutical Group Inc., a woman-owned small business, holds a single-award indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at up to $4,999,999 through December 2025. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide.

Through this contract vehicle, DMS Pharmaceutical Group has been awarded multiple delivery orders to provide specialized medications such as Xolair, Trikafta, Keytruda, Botox, Nucala, and various other prescription drugs and medical supplies. The delivery orders, which do not have set-aside designations, cover a wide range of medical needs, including oncology treatments, contraceptives, auto-injectors, and other pharmaceutical products. DMS Pharmaceutical Group's facility in Park Ridge, Illinois serves as the primary place of performance for fulfilling these delivery orders to the DLA's medical supply chain.